Uses of No - Lapin

No - Lapin is an antiallergic drug whose main active ingredient is Loratadin. No - Lapin has a selective long-acting antagonistic effect on peripheral H1 receptors and has no CNS depressant effects.
In addition, the drug No - Lapin also works against itching and urticaria related to histamine. However, in cases of severe histamine release such as anaphylaxis, the drug is not protective or clinically helpful.
Drug No - Lapin has no sedative effect, in contrast to the sedative side effects of first-generation antihistamines.
No - Lapin is indicated for use in the symptoms associated with allergic rhinitis such as sneezing, runny nose, itchy nose, as well as itchy and burning eyes. These symptoms will subside quickly after using the drug. Besides, No - Lapin is also indicated in the treatment of symptoms and signs of chronic urticaria and other allergic skin disorders.

Drug No - Lapin is used orally. Dosage depends on age and weight:
For adults and children over 12 years old: take 1 tablet of 10mg per day or take 2 teaspoons, equivalent to 10ml of No - Lapin syrup per day. For children aged 2-12 years who weigh over 30kg: take 10ml of loratadine syrup daily. For children from 2-12 years old under 30kg: take 5ml of loratadine syrup per day. When patients take an overdose of No - Lapin, symptoms such as drowsiness, rapid heart rate and headache may appear. At that time, it is necessary to immediately treat the symptoms and provide supportive treatment for the patient.
When using an overdose of No - Lapin drug, the patient can vomit on his own, but it is best to induce vomiting for the patient by using ipeca. However, in patients with reduced consciousness, vomiting should not be caused. The effects of ipeca are supported by mechanical movements and by giving the patient 240 to 360 ml of water to drink. If the patient does not vomit within 15 minutes, the dose of ipeca should be repeated. During the time of vomiting, care should be taken not to allow the patient to breathe vomit into the respiratory tract, especially in children. If vomiting cannot be successfully induced or there are contraindications, gastric lavage should be performed with physiological saline. Saline detergents conduct water into the intestinal tract by osmosis, which in turn also has a rapid dilution effect of the contents of the intestine. No - Lapin is not eliminated by dialysis to any extent. It is necessary to monitor the patient after emergency treatment.

No - Lapin drug is quite safe for users, rarely serious side effects occur. Common side effects include fatigue, headache, drowsiness, dry mouth, manifestations of gastrointestinal disturbances such as vomiting, nausea, gastritis, and allergic symptoms such as rash.
No - Lapin drug used in practice by patients rarely occurs hair loss, anaphylaxis or abnormal liver function.
Controlled clinical studies in children show that symptoms such as headache, anxiety and sedation are very rare in this subject.

No - Lapin is contraindicated for patients with a history of hypersensitivity or allergy to any of the ingredients in the drug.
Use caution when using No - Lapin for the following subjects:
Use lower doses in patients with severe liver failure due to decreased clearance of loratadine. For this population, the starting dose is 5mg or 5ml daily or 10mg or 10ml every 2 days. For children under 2 years of age, the safety and efficacy of the drug has not been established. For women who are pregnant, the safety of using No - Lapin has not been confirmed. Therefore, it is necessary to weigh the benefits and risks before deciding to use this object. No - Lapine drug is excreted in breast milk and increases the risk of antihistamines in newborns and premature babies, so when using the drug, it is necessary to stop breastfeeding or the mother must stop using the drug during lactation. . Patients should stop using No - Lapin about 48 hours before conducting skin tests because antihistamines may eliminate or reduce the signs of positive disease-detecting reactions.
Loratadine plasma concentrations are increased when co-administered with other drugs such as ketoconazole, erythromycin, cimetidine, but there is no significant change. Therefore, caution should be exercised when No - Lapin is used concomitantly with drugs that inhibit hepatic metabolism until the results of drug interaction studies are available.
No - Lapin is an antihistamine widely used in the treatment of allergic rhinitis and symptoms of urticaria and allergies on the skin. The drug rarely causes serious unwanted effects. However, patients need to consult their doctor and carefully read the instructions for use before deciding to use the drug.